{"uri": "eng-9429070", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Infection", "type": "wiki", "score": 100, "label": {"eng": "Infection"}}, {"uri": "http://en.wikipedia.org/wiki/National_University_of_Singapore", "type": "org", "score": 93, "label": {"eng": "National University of Singapore"}}, {"uri": "http://en.wikipedia.org/wiki/Antibiotic", "type": "wiki", "score": 82, "label": {"eng": "Antibiotic"}}, {"uri": "http://en.wikipedia.org/wiki/Bacteria", "type": "wiki", "score": 82, "label": {"eng": "Bacteria"}}, {"uri": "http://en.wikipedia.org/wiki/Mycobacterium", "type": "wiki", "score": 81, "label": {"eng": "Mycobacterium"}}, {"uri": "http://en.wikipedia.org/wiki/Medication", "type": "wiki", "score": 76, "label": {"eng": "Medication"}}, {"uri": "http://en.wikipedia.org/wiki/Nontuberculous_mycobacteria", "type": "wiki", "score": 76, "label": {"eng": "Nontuberculous mycobacteria"}}, {"uri": "http://en.wikipedia.org/wiki/Relapse", "type": "wiki", "score": 70, "label": {"eng": "Relapse"}}, {"uri": "http://en.wikipedia.org/wiki/Respiratory_disease", "type": "wiki", "score": 68, "label": {"eng": "Respiratory disease"}}, {"uri": "http://en.wikipedia.org/wiki/Respiratory_tract_infection", "type": "wiki", "score": 65, "label": {"eng": "Respiratory tract infection"}}, {"uri": "http://en.wikipedia.org/wiki/Antimicrobial_resistance", "type": "wiki", "score": 60, "label": {"eng": "Antimicrobial resistance"}}, {"uri": "http://en.wikipedia.org/wiki/Bronchiectasis", "type": "wiki", "score": 60, "label": {"eng": "Bronchiectasis"}}, {"uri": "http://en.wikipedia.org/wiki/Cystic_fibrosis", "type": "wiki", "score": 60, "label": {"eng": "Cystic fibrosis"}}, {"uri": "http://en.wikipedia.org/wiki/Chronic_obstructive_pulmonary_disease", "type": "wiki", "score": 60, "label": {"eng": "Chronic obstructive pulmonary disease"}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 60, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Efficacy", "type": "wiki", "score": 56, "label": {"eng": "Efficacy"}}, {"uri": "http://en.wikipedia.org/wiki/Public_health", "type": "wiki", "score": 56, "label": {"eng": "Public health"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmacology", "type": "wiki", "score": 53, "label": {"eng": "Pharmacology"}}, {"uri": "http://en.wikipedia.org/wiki/Interdisciplinarity", "type": "wiki", "score": 53, "label": {"eng": "Interdisciplinarity"}}, {"uri": "http://en.wikipedia.org/wiki/Translation_(biology)", "type": "wiki", "score": 49, "label": {"eng": "Translation (biology)"}}, {"uri": "http://en.wikipedia.org/wiki/Paradigm", "type": "wiki", "score": 49, "label": {"eng": "Paradigm"}}, {"uri": "http://en.wikipedia.org/wiki/Nanyang_Technological_University", "type": "org", "score": 36, "label": {"eng": "Nanyang Technological University"}}], "eventDate": "2024-03-25", "totalArticleCount": 6, "title": {"eng": "Breakthrough antibiotic shows promise against obstinate mycobacterial infections"}, "summary": {"eng": "A team of scientists led by Prof Guillermo Bazan from NUS Institute for Functional Intelligent Materials (I-FIM) has developed a novel antibiotic named COE-PNH2 that is capable of combating hard-to-treat mycobacterial lung infections. Such infections, which are notorious for resisting conventional treatment, pose a serious health threat, especially to the elderly and those with underlying conditions. COE-PNH2 disrupts bacterial defences, eliminates the bacteria more thoroughly, and exhibits low f"}, "location": null, "categories": [{"uri": "dmoz/Health/Conditions_and_Diseases/Infectious_Diseases", "label": "dmoz/Health/Conditions and Diseases/Infectious Diseases", "wgt": 80}, {"uri": "dmoz/Science/Biology/Immunology", "label": "dmoz/Science/Biology/Immunology", "wgt": 100}, {"uri": "dmoz/Health/Specific_Substances/Cranberries", "label": "dmoz/Health/Specific Substances/Cranberries", "wgt": 84}, {"uri": "news/Health", "label": "news/Health", "wgt": 68}], "articleCounts": {"eng": 6}, "sentiment": 0.02745098039215677, "wgt": 449020800, "relevance": 1}